Breakthrough Chemistry, Inc. (BKTH)

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Pharmaceuticals	18.92K	13.82K	16.72K
Pharmaceuticals Growth	36.86%	-17.34%	-
Total	18.92K	13.82K	16.72K
Total Growth	36.86%	-17.34%	-

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Canada	18.92K	13.82K	16.72K
Canada Growth	36.86%	-17.34%	-
Total	18.92K	13.82K	16.72K
Total Growth	36.86%	-17.34%	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error